OpenBIS 20210430101617692-12811 Version 1
View contentSEEK ID: https://seek.lisym.org/data_files/498?version=1
| original/DEFAULT/20210325_CFU-E_SHP1_PFA_MeOH.zip | 5.02 MB |
|
| original/DEFAULT/Specimen_001_SHP1_R6_002.fcs | 1.78 MB |
|
| original/DEFAULT/Specimen_001_SHP1_R7_004.fcs | 1.78 MB |
|
| original/DEFAULT/Specimen_001_unstained_R6_001.fcs | 1.72 MB |
|
| original/DEFAULT/Specimen_001_unstained_R7_003.fcs | 1.71 MB |
|
Export PNG
Creators and Submitter
Views: 1209 Downloads: 87
Created: 18th Nov 2021 at 13:21
TagsThis item has not yet been tagged.
AttributionsNone
Version History
Version 1 (earliest) Created 18th Nov 2021 at 13:21 by Alain Becam
No revision comments
Related items
Liver Systems Medicine : striving to develop non-invasive methods for diagnosing and treating NAFLD by combining mathematical modeling and biological research. LiSyM, is a multidisciplinary research network, in which molecular and cell biologists, clinical researchers, pharmacologists and experts in mathematical modeling examine the liver in its entirety. LiSyM research focuses on the metabolic liver disease non-alcoholic fatty liver disease (NAFLD), which includes non-alcoholic steatohepatitis ...
Projects: LiSyM Core Infrastructure and Management (LiSyM-PD), LiSyM Pillar I: Early Metabolic Injury (LiSyM-EMI), LiSyM Pillar II: Chronic Liver Disease Progression (LiSyM-DP), LiSyM Pillar III: Regeneration and Repair in Acute-on-Chronic Liver Failure (LiSyM-ACLF), LiSyM Pillar IV: Liver Function Diagnostics (LiSyM-LiFuDi), Model Guided Pharmacotherapy In Chronic Liver Disease (LiSyM-MGP), Molecular Steatosis - Imaging & Modeling (LiSyM-MSIM), The Hedgehog Signalling Pathway (LiSyM-JGMMS), Multi-Scale Models for Personalized Liver Function Tests (LiSyM-MM-PLF), LiSyM PALs, Project Management PTJ, LiSyM network, LiSyM Scientific Leadership Team (LiSyM-LT)
Web page: https://www.lisym.org/
In chronic diseases, at some point the liver can suddenly stop functioning. This is called acute-on-chronic liver failure, or ACLF. This is the leading cause of death in liver patients and is often provoked by the use of transcription or freely available drugs or alcohol abuse. For this condition we need an effective treatment quickly. LiSyM-Pillar III researches the factors that contribute significantly to ACLF. What exactly happens then? Are there any early signs that would enable ACLF to be ...
Programme: LiSyM: Liver Systems Medicine
Public web page: http://www.lisym.org/our-work/pillar-research
Start date: 1st Jan 2016
Submitter: Martin Golebiewski
Studies: OpenBIS E520, OpenBIS E521, OpenBIS E522
Assays: OpenBIS 01_SCC_11928, OpenBIS 01_SCC_11934, OpenBIS 01_SCC_11976, OpenBIS 02_T_11979, OpenBIS 03_FACS_11972, OpenBIS 03_FACS_11974, OpenBIS 03_FACS_12091, OpenBIS 03_FACS_12099, OpenBIS 03_FACS_12101, OpenBIS 03_FACS_12102, OpenBIS FILES, OpenBIS FILES, OpenBIS FILES, OpenBIS FILES
Submitter: Alain Becam
Investigation: LiSyM Pillar III: Regeneration and Repair in Ac...
Assays: OpenBIS FILES
Automatically generated assay to host openbis files that are linked to the original OpenBIS experiment. Its content and linked data files will be updated by the system if automatic synchronization was selected.
Submitter: Alain Becam
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: LiSyM Pillar III: Regeneration and Repair in Ac...
Study: OpenBIS E522
